Suppression of the Nuclear Factor-κB Activation Pathway by Spice-Derived Phytochemicals: Reasoning for Seasoning
BHARAT B. AGGARWAL,
SHISHIR SHISHODIA,
Corresponding Author
BHARAT B. AGGARWAL
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Address for correspondence: Bharat B. Aggarwal, Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Box 143, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Voice: 713-792-3503/6459; fax: 713-794-1613. e-mail: [email protected]Search for more papers by this authorSHISHIR SHISHODIA
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Search for more papers by this authorBHARAT B. AGGARWAL,
SHISHIR SHISHODIA,
Corresponding Author
BHARAT B. AGGARWAL
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Address for correspondence: Bharat B. Aggarwal, Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Box 143, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Voice: 713-792-3503/6459; fax: 713-794-1613. e-mail: [email protected]Search for more papers by this authorSHISHIR SHISHODIA
Cytokine Research Laboratory, Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
Search for more papers by this authorAbstract
Abstract: The activation of nuclear transcription factor κB has now been linked with a variety of inflammatory diseases, including cancer, atherosclerosis, myocardial infarction, diabetes, allergy, asthma, arthritis, Crohn's disease, multiple sclerosis, Alzheimer's disease, osteoporosis, psoriasis, septic shock, and AIDS. Extensive research in the last few years has shown that the pathway that activates this transcription factor can be interrupted by phytochemicals derived from spices such as turmeric (curcumin), red pepper (capsaicin), cloves (eugenol), ginger (gingerol), cumin, anise, and fennel (anethol), basil and rosemary (ursolic acid), garlic (diallyl sulfide, S-allylmercaptocysteine, ajoene), and pomegranate (ellagic acid). For the first time, therefore, research provides “reasoning for seasoning.”
REFERENCES
- 1 Garg, A. & B.B. Aggarwal. 2002. Nuclear transcription factor-κB as a target for cancer drug development. Leukemia 16: 1053–1068.
- 2 Kumar, A., Y. Takada, A.M. Boriek & B.B. Aggarwal. 2004. Nuclear factor-κB: its role in health and diseases. J. Mol. Med. 82: 434–448.
- 3 Shishodia, S. & B.B. Aggarwal. 2004. Nuclear factor (NF)-κB regulates the expression of genes involved in transformation, proliferation, invasion, angiogenesis and metastasis of cancer. Cancer Treat. Res. 119: 139–173.
- 4 Lin, A. & M. Karin. 2003. NF-κB in cancer: a marked target. Semin. Cancer Biol. 13: 107–114.
- 5 Orlowski, R.Z. & A.S. Baldwin, Jr. 2002. NF-κB as a therapeutic target in cancer. Trends Mol. Med. 8: 385–389.
- 6 Valen, G., Z.Q. Yan & G.K. Hansson. 2001. Nuclear factor κ-B and the heart. J. Am. Coll. Cardiol. 38: 307–314.
- 7 Jones, W.K., M. Brown, X. Ren, et al. 2003. NF-κB as an integrator of diverse signaling pathways: the heart of myocardial signaling? Cardiovasc. Toxicol. 3: 229–254.
- 8 Shoelson, S.E., J. Lee & M. Yuan. 2003. Inflammation and the IKK β/I κ B/NF-κ B axis in obesity- and diet-induced insulin resistance. Int. J. Obes. Relat. Metab. Disord. 27 (Suppl. 3): S49–S52.
- 9 Yang, L., L. Cohn, D.H. Zhang, et al. 1998. Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188: 1739–1750.
- 10 Das, J., C.H. Chen, L. Yang, et al. 2001. A critical role for NF-κB in GATA3 expression and TH2 differentiation in allergic airway inflammation. Nat. Immunol. 2: 45–50.
- 11 Gagliardo, R., P. Chanez, M. Mathieu, et al. 2003. Persistent activation of nuclear factor-κB signaling pathway in severe uncontrolled asthma. Am. J. Respir. Crit. Care Med. 168: 1190–1198.
- 12 Roshak, A.K., J.F. Callahan & S.M. Blake. 2002. Small-molecule inhibitors of NF-κB for the treatment of inflammatory joint disease. Curr. Opin. Pharmacol. 2: 316–321.
- 13 van Heel, D.A., I.A. Udalova, A.P. DeSilva, et al. 2002. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF-κB transcription factors. Hum. Mol. Genet. 11: 1281–1289.
- 14 Huang, C.J., R. Nazarian, J. Lee, et al. 2002. Tumor necrosis factor modulates transcription of myelin basic protein gene through nuclear factor κB in a human oligodendroglioma cell line. Int. J. Dev. Neurosci. 20: 289–296.
- 15 Mattson, M.P. & S. Camandola. 2001. NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107: 247–254.
- 16 Kaltschmidt, B., M. Uherek, B. Volk, et al. 1997. Transcription factor NF-κB is activated in primary neurons by amyloid β peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94: 2642–2647.
- 17 Burke, J.R. 2003. Targeting I κ B kinase for the treatment of inflammatory and other disorders. Curr. Opin. Drug Discov. Dev. 6: 720–728.
- 18 Yamamoto, Y. & R.B. Gaynor. 2001. Role of the NF-κB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 1: 287–296.
- 19 Yamamoto, Y. & R.B. Gaynor. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. 107: 135–142.
- 20 Gorman, C. & A. Park. 2004. The fires within. Time February 23. 163(8): 42–46.
- 21 Shobana, S. & K.A. Naidu. 2000. Antioxidant activity of selected Indian spices. Prostaglandins Leukot. Essent. Fatty Acids 62: 107–110.
- 22 Aggarwal, B.B., A. Kumar & A.C. Bharti. 2003. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23: 363–398.
- 23 Singh, S. & B.B. Aggarwal. 1995. Activation of transcription factor NF-k B is suppressed by curcumin (diferuloylmethane). J. Biol. Chem. 270: 24995–25000.
- 24 Bharti, A.C., N. Donato, S. Singh & B.B. Aggarwal. 2003. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-β B and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101: 1053–1062.
- 25 Mukhopadhyay, A., S. Banerjee, L.J. Stafford, et al. 2002. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21: 8852–8861.
- 26 Mukhopadhyay, A., C. Bueso-Ramos, D. Chatterjee, et al. 2001. Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene 20: 7597–7609.
- 27 Mehta, K., P. Pantazis, T. McQueen & B.B. Aggarwal. 1997. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8: 470–481.
- 28 Anto, R.J., A. Mukhopadhyay, K. Denning & B.B. Aggarwal. 2002. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Carcinogenesis 23: 143–150.
- 29 Bharti, A.C., S. Shishodia, J.M. Reuben, et al. 2003. Nuclear factor-κB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 103: 3175–3184.
- 30 Bharti, A.C., Y. Takada & B.B. Aggarwal. 2004. Curcumin (diferuloylmethane) inhibits RANK ligand-induced NF-κ B activation in osteoclast precursors and suppresses osteoclastogenesis. J. Immunol. 172: 5940–5947.
- 31 Shishodia, S., P. Potdar, C.G. Gairola & B.B. Aggarwal. 2003. Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-κB activation through inhibition of IκBα kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24: 1269–1279.
- 32 Kumar, A., S. Dhawan, N.J. Hardegen & B.B. Aggarwal. 1998. Curcumin (diferuloylmethane) inhibition of tumor necrosis factor (TNF)-mediated adhesion of monocytes to endothelial cells by suppression of cell surface expression of adhesion molecules and of nuclear factor-κB activation. Biochem. Pharmacol. 55: 775–783.
- 33 Reddy, S. & B.B. Aggarwal. 1994. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 341: 19–22.
- 34 Aggarwal, B.B., A. Kumar, M.S. Aggarwal & S. Shishodia. 2004. Curcumin derived from turmeric (Curcuma longa): a spice for all seasons. In Phytochemicals in Cancer Chemoprevention. D. Bagchi & H.G. Preuss, Eds.: 349–387. CRC Press. Boca Raton, FL.
- 35 Hail, N., Jr. & R. Lotan. 2002. Examining the role of mitochondrial respiration in vanilloid-induced apoptosis. J. Natl. Cancer Inst. 94: 1281–1292.
- 36 Surh, Y.J. 2002. More than spice: capsaicin in hot chili peppers makes tumor cells commit suicide. J. Natl. Cancer Inst. 94: 1263–1265.
- 37 Singh, S., K. Natarajan & B.B. Aggarwal. 1996. Capsaicin (8-methyl-N-vanillyl-6-nonenamide) is a potent inhibitor of nuclear transcription factor-κ B activation by diverse agents. J. Immunol. 157: 4412–4420.
- 38 Ruberto, G., M.T. Baratta, S.G. Deans & H.J. Dorman. 2000. Antioxidant and antimicrobial activity of Foeniculum vulgare and Crithmum maritimum essential oils. Planta Med. 66: 687–693.
- 39 Albert-Puleo, M. 1980. Fennel and anise as estrogenic agents. J. Ethnopharmacol. 2: 337–344.
- 40 Sen, C.K., K.E. Traber & L. Packer. 1996. Inhibition of NF-κ B activation in human T-cell lines by anetholdithiolthione. Biochem. Biophys. Res. Commun. 218: 148–153.
- 41 Chainy, G.B., S.K. Manna, M.M. Chaturvedi & B.B. Aggarwal. 2000. Anethole blocks both early and late cellular responses transduced by tumor necrosis factor: effect on NF-κB, AP-1, JNK, MAPKK and apoptosis. Oncogene 19: 2943–2950.
- 42 Murakami, Y., M. Shoji, S. Hanazawa, et al. 2003. Preventive effect of bis-eugenol, a eugenol ortho dimer, on lipopolysaccharide-stimulated nuclear factor κ B activation and inflammatory cytokine expression in macrophages. Biochem. Pharmacol. 66: 1061–1066.
- 43 Yamahara, J., H.Q. Rong, Y. Naitoh, et al. 1989. Inhibition of cytotoxic drug-induced vomiting in suncus by a ginger constituent. J. Ethnopharmacol. 27: 353–355.
- 44 Yamahara, J., M. Mochizuki, H.Q. Rong, et al. 1988. The anti-ulcer effect in rats of ginger constituents. J. Ethnopharmacol. 23: 299–304.
- 45 Bode, A.M., W.Y. Ma, Y.J. Surh & Z. Dong. 2001. Inhibition of epidermal growth factor-induced cell transformation and activator protein 1 activation by [6]-gingerol. Cancer Res. 61: 850–853.
- 46 Tjendraputra, E., V.H. Tran, D. Liu-Brennan, et al. 2001. Effect of ginger constituents and synthetic analogues on cyclooxygenase-2 enzyme in intact cells. Bioorg. Chem. 29: 156–163.
- 47 Koo, K.L., A.J. Ammit, V.H. Tran, et al. 2001. Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation. Thromb. Res. 103: 387–397.
- 48 Shishodia, S., S. Majumdar, S. Banerjee & B.B. Aggarwal. 2003. Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res. 63: 4375–4383.
- 49 Dirsch, V.M., D.S. Antlsperger, H. Hentze & A.M. Vollmar. 2002. Ajoene, an experimental anti-leukemic drug: mechanism of cell death. Leukemia 16: 74–83.
- 50 Geng, Z., Y. Rong & B.H. Lau. 1997. S-Allyl cysteine inhibits activation of nuclear factor k B in human T cells. Free Radic. Biol. Med. 23: 345–350.
- 51 Ide, N. & B.H. Lau. 2001. Garlic compounds minimize intracellular oxidative stress and inhibit nuclear factor-κ B activation. J. Nutr. 131: 1020S–1026S.
- 52 Keiss, H.P., V.M. Dirsch, T. Hartung, et al. 2003. Garlic (Allium sativum L.) modulates cytokine expression in lipopolysaccharide-activated human blood thereby inhibiting NF-κB activity. J. Nutr. 133: 2171–2175.
- 53 Aviram, M., L. Dornfeld, M. Kaplan, et al. 2002. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Exp. Clin. Res. 28: 49–62.
- 54 Aviram, M. & L. Dornfeld. 2001. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158: 195–198.
- 55 Schubert, S.Y., I. Neeman & N. Resnick. 2002. A novel mechanism for the inhibition of NF-κB activation in vascular endothelial cells by natural antioxidants. FASEB J. 16: 1931–1933.
- 56 Surh, Y.J. 2002. Anti-tumor promoting potential of selected spice ingredients with antioxidative and anti-inflammatory activities: a short review. Food Chem. Toxicol. 40: 1091–1097.
